Sign In
Buy CMRX
$8.54
+0 (+0%)
At Close: Jul 18, 2025
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 19.)
Biomerica, Inc. (NASDAQ...
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Michael Sherman Is The CEO, President & Director of Chimerix, Inc. (NASDAQ:CMRX) And They Just Spent US$106k On Shares
10:26am, Wednesday, 18'th Mar 2020
Investors who take an interest in Chimerix, Inc. (NASDAQ:CMRX) should definitely note that the CEO, President...
Chimerix Inc (CMRX) CEO Michael A. Sherman Bought $–…5,84' of Shares
12:00am, Monday, 16'th Mar 2020All You Need to Know About Chimerix (CMRX) Rating Upgrade to Buy
05:00pm, Friday, 28'th Feb 2020
Chimerix (CMRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
All You Need to Know About Chimerix (CMRX) Rating Upgrade to Buy
12:00am, Friday, 28'th Feb 2020Chimerix to Present at Cowen and Company 40th Annual Health Care Conference
01:00pm, Wednesday, 26'th Feb 2020
Chimerix (CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that Mike Sherman, Chief Executive Office
NIO, FCEL among premarket gainers
02:24pm, Tuesday, 25'th Feb 2020
VivoPower International PLC (NASDAQ:VVPR) +57% on 1H results.Cocrystal Pharma (NASDAQ:COCP) +54%.Mallinckrodt plc (NYSE:MNK) +38% on Q4 results and global opioid settlement.NIO (NYSE:NIO) +34% aft
The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
01:28pm, Tuesday, 25'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainst
Chimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational Update
12:00pm, Tuesday, 25'th Feb 2020
- Successful DSTAT End of Phase 2 Meeting with FDA Confirms Phase 3 Readiness; First Patient Visit Expected mid-2020 in 1L AML - - Brincidofovir pre-NDA Meeting Scheduled.
Chimerix, Inc. to Host Earnings Call
11:30am, Tuesday, 25'th Feb 2020
NEW YORK, NY / ACCESSWIRE / February 25, 2020 / Chimerix, Inc. (NASDAQ:CMRX) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 25, 2020 at 8:3
Chimerix Appoints Pratik S. Multani, M.D., to Board of Directors
01:00pm, Monday, 24'th Feb 2020
Chimerix (CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced the appointment of Pratik S. Multani, M.D
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
11:38pm, Sunday, 23'rd Feb 2020
Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a handful of FDA verdicts. M
Chimerix to Report Fourth Quarter and Year End 2019 Financial Results and Provide an Operational Update on February 25, 2020
01:00pm, Tuesday, 18'th Feb 2020
Chimerix (CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that it will host a live conference call
